Chemomab Therapeutics (CMMB) Net Income (QoQ) (2018 - 2025)
Chemomab Therapeutics (CMMB) Net Income (QoQ) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Chemomab Therapeutics |
852.08 Mn |
841.71 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-1,025.20% |
| Dec 31, 2024 |
-815.68% |
| Sep 30, 2024 |
-4.08% |
| Jun 30, 2024 |
-6.13% |
| Mar 31, 2024 |
13.20% |
| Dec 31, 2023 |
-18.47% |
| Sep 30, 2023 |
-46.96% |
| Jun 30, 2023 |
-9.29% |
| Mar 31, 2023 |
5.56% |
| Dec 31, 2022 |
2.13% |
| Sep 30, 2022 |
11.02% |
| Jun 30, 2022 |
242.59% |
| Mar 31, 2022 |
-1.35% |
| Dec 31, 2021 |
-69.68% |
| Sep 30, 2021 |
-7.15% |
| Dec 31, 2019 |
-154.84% |
| Sep 30, 2019 |
904.43% |
| Jun 30, 2019 |
-90.87% |
| Mar 31, 2019 |
914.80% |
| Dec 31, 2018 |
-27.75% |
